Nothing Special   »   [go: up one dir, main page]

Milosevic et al., 2017 - Google Patents

Cell‐and region‐specific expression of depression‐related protein p11 (S100a10) in the brain

Milosevic et al., 2017

View PDF
Document ID
15480396181988859356
Author
Milosevic A
Liebmann T
Knudsen M
Schintu N
Svenningsson P
Greengard P
Publication year
Publication venue
Journal of Comparative Neurology

External Links

Snippet

ABSTRACT P11 (S100a10), a member of the S100 family of proteins, has widespread distribution in the vertebrate body, including in the brain, where it has a key role in membrane trafficking, vesicle secretion, and endocytosis. Recently, our laboratory has …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Similar Documents

Publication Publication Date Title
Milosevic et al. Cell‐and region‐specific expression of depression‐related protein p11 (S100a10) in the brain
Bonafina et al. GDNF and GFRα1 are required for proper integration of adult-born hippocampal neurons
Brill et al. A dlx2-and pax6-dependent transcriptional code for periglomerular neuron specification in the adult olfactory bulb
Mani et al. Neuroanatomical characterization of a growth hormone secretagogue receptor‐green fluorescent protein reporter mouse
Gharami et al. Brain‐derived neurotrophic factor over‐expression in the forebrain ameliorates Huntington’s disease phenotypes in mice
Leyva-Díaz et al. FLRT3 is a Robo1-interacting protein that determines Netrin-1 attraction in developing axons
Marshall et al. Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus
Marshall et al. Olig2 directs astrocyte and oligodendrocyte formation in postnatal subventricular zone cells
Sardi et al. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain
DeChiara et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo
Stegeman et al. Loss of Usp9x disrupts cortical architecture, hippocampal development and TGFβ-mediated axonogenesis
Glasco et al. The mouse Wnt/PCP protein Vangl2 is necessary for migration of facial branchiomotor neurons, and functions independently of Dishevelled
Cioni et al. SEMA3A signaling controls layer-specific interneuron branching in the cerebellum
Bustos et al. NMDA receptor subunit composition controls dendritogenesis of hippocampal neurons through CAMKII, CREB‐P, and H3K27ac
Rath et al. Expression of the Otx2 homeobox gene in the developing mammalian brain: embryonic and adult expression in the pineal gland
Ren et al. Downregulated nuclear factor E2-related factor 2 (Nrf2) aggravates cognitive impairments via neuroinflammation and synaptic plasticity in the senescence-accelerated mouse prone 8 (SAMP8) mouse: a model of accelerated senescence
Mo et al. Early growth response 1 (Egr‐1) directly regulates GABAA receptor α2, α4, and θ subunits in the hippocampus
Iwakura et al. Qualitative and quantitative re‐evaluation of epidermal growth factor‐ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target‐derived neurotrophic signaling (Part 1)
Rosas‐Arellano et al. Expression of GABAρ receptors in the neostriatum: localization in aspiny, medium spiny neurons and GFAP‐positive cells
Zhao et al. A molecular mechanism that regulates medially oriented axonal growth of upper layer neurons in the developing neocortex
Ueda et al. Involvement of sonic hedgehog and notch signaling in regenerative neurogenesis in adult zebrafish optic tectum after stab injury
Leong et al. Methyl-CpG binding protein 2 (Mecp2) regulates sensory function through Sema5b and Robo2
Mizuno et al. Role of an adaptor protein Lin‐7B in brain development: possible involvement in autism spectrum disorders
Jacquier et al. Expanding the phenotypic variability of MORC2 gene mutations: from Charcot‐Marie‐Tooth disease to late‐onset pure motor neuropathy
Kikuchi et al. Involvement of SRF coactivator MKL 2 in BDNF‐mediated activation of the synaptic activity‐responsive element in the Arc gene